Fig. 2From: The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysisForest plot of the efficacy outcomes between anti-VEGF and laserBack to article page